# CELLINK to acquire Ginolis for EUR 70M

CELLINK AB has agreed to acquire all shares of Ginolis Oy, a Finnish diagnostics automation and robotics company, for EUR 70 million on a cash- and debt-free basis. The acquisition will strengthen CELLINK's bioconvergence position.

- Type: Acquisition
- Announced: 2021-02-15
- Where: Finland
- Value: $84.7M (70.0M EUR)
- Status: announced
- Products: advanced robotics systems, diagnostics automation solutions
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CELLINK](https://endata.com/companies/41154.md) (acquirer)
- [Ginolis](https://endata.com/companies/53236.md) (target)

## Sources

- [news.cision.com](https://news.cision.com/bico-group/r/cellink-has-entered-into-an-agreement-to-acquire-the-advanced-robotics-and-diagnostics-automation-co,c3286729), 2021-02-15: "CELLINK has entered into an agreement with the shareholders of Ginolis Oy to acquire all shares for a purchase price on cash- and debt-free basis of 70M euros."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.